shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > No final recommendation on vaccine for children and third dose in NTGAI meet Official sources

No final recommendation on vaccine for children and third dose in NTGAI meet: Official sources

Updated on: 07 December,2021 03:13 PM IST  |  New Delhi
Agencies |

"The meeting put light on COVID-19 vaccination, additional doses and vaccination for children but due to no consensus over the issues final recommendation couldn't be made," sources said

No final recommendation on vaccine for children and third dose in NTGAI meet: Official sources

Photo for representational purpose

After a long meeting of the National Technical Advisory Group on Immunization (NTAGI) on Monday, no final recommendation was made on additional COVID-19 vaccine dose and vaccine for children, informed the official sources. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting, official sources told ANI. 


"The meeting put light on COVID-19 vaccination, additional doses and vaccination for children but due to no consensus over the issues final recommendation couldn't be made," sources said.


As earlier, it has been reported that NTAGI will be coming with comprehensive policies for both booster dose and vaccination for children. There is a difference between the booster dose and the additional dose. The booster dose is given after a predefined period after the primary two-dose have been given while an additional dose is given to those people who have basic problems with their immune system. With the primary two doses, if the immune function is not built properly, the additional dose of the COVID-19 vaccine is given. 


This decision has also to be taken in the context as India reports 23 new cases of COVID-19 Omicron variant. On administration of booster doses, the Union Health Minister Mansukh Mandaviya had recently informed the Lok Sabha that the National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) were deliberating and considering scientific evidence related to this aspect.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK